Therapeutic potential of surgery for metastatic colorectal cancer

References

• Surveillance Research Program Fast Stats: An interactive tool for access to SEER cancer statistics. National Cancer Institute. Available at http://seer.cancer.gov/faststats. Cited 2011 29 May.
   Google Scholar
• Van Steenbergen LN, Elferink MAG, Krijnen P, Lemmens VEPP, Siesling S, Rutten HJT, Improved survival of colon cancer due to improved treatment and detection: a nationwide population-based study in The Netherlands 1989–2006. Ann Oncol 2010;21:2206–12.
   PubMed Web of Science ®Google Scholar
• Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ, Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med 2000;343:905–14.
   PubMed Web of Science ®Google Scholar
• de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000;18:2938–47.
   PubMed Web of Science ®Google Scholar
• Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2004;22:23–30.
   PubMed Web of Science ®Google Scholar
• Saltz LB, Clarke S, Díaz-Rubio E, Scheithauer W, Figer A, Wong R, Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a Randomized Phase III Study. J Clin Oncol 2008;26:2013–19.
   PubMed Web of Science ®Google Scholar
• Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335–42.
   PubMed Web of Science ®Google Scholar
• Van Cutsem E, KÃhne C-H, Hitre E, Zaluski J, Chang Chien C-R, Makhson A, Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med 2009;360:1408–17.
   PubMed Web of Science ®Google Scholar
• Bokemeyer C, Bondarenko I, Makhson A, Hartmann JT, Aparicio J, de Braud F, Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer. J Clin Oncol 2009;27:663–71.
   PubMed Web of Science ®Google Scholar
• Okines A, Puerto OD, Cunningham D, Chau I, Van Cutsem E, Saltz L, Surgery with curative-intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phase-III NO16966 trial. Br J Cancer 2009;101:1033–8.
   PubMed Web of Science ®Google Scholar
• Bengmark S, Hafstrom L. The natural history of primary and secondary malignant tumours of the liver. Cancer 1969;23:198–202.
   PubMed Web of Science ®Google Scholar
• Fong Y, Kemeny N, Paty P, Blumgart LH, Cohen AM. Treatment of colorectal cancer: Hepatic metastasis. Semin Surg Oncol 1996;12:219–52.
   PubMed Web of Science ®Google Scholar
• Kemeny N, Fata F. Arterial, portal or systemic chemotherapy for patients with hepatic metastasis of colorectal carcinoma. Journal Hepatobiliary Pancreat Surg 1999;6:39–49.
   PubMedGoogle Scholar
• Steele GJ, Ravikumar TS. Resection of hepatic metastases from colorectal metastases: biologic perspectives. Ann Surg 1989;210:127–38.
   PubMed Web of Science ®Google Scholar
• Wagner JS, Adson MA, Van Heerden JA, Adson MH, Ilstrup DM. The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg 1984;199:502–8.
   PubMed Web of Science ®Google Scholar
• Scheele J. Hepatectomy for liver metastases. Br J Surg 1993;80:274–6.
   PubMed Web of Science ®Google Scholar
• Nordlinger B, Quilichini MA, Parc R, Hannoun L, Delva E, Huguet C. Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patients. Ann Surg 1987;205:256–63.
   PubMed Web of Science ®Google Scholar
• Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999;230:309–18.
   PubMed Web of Science ®Google Scholar
• Garcea G, Lloyd TD, Aylott C, Maddern G, Berry DP. The emergent role of focal liver ablation techniques in the treatment of primary and secondary liver tumours. Eur J Cancer 2003;39:2150–64.
   PubMed Web of Science ®Google Scholar
• Otto G, Düber C, Hoppe-Lotichius M, König J, Heise M, Pitton MB. Radiofrequency ablation as first-line treatment in patients with early colorectal liver metastases amenable to surgery. Ann Surg 2010;251:796–803.
   PubMed Web of Science ®Google Scholar
• Hammill CW, Billingsley KG, Cassera MA, Wolf RF, Ujiki MB, Hansen PD. Outcome after laparoscopic radiofrequency ablation of technically resectable colorectal liver metastases. Ann Surg Oncol 2011; Epub ahead of print.
   PubMed Web of Science ®Google Scholar
• Pawlik TM, Schulick RD, Choti MA. Expanding criteria for resectability of colorectal liver metastases. Oncologist 2008;13:51–64.
   PubMed Web of Science ®Google Scholar
• Brouquet A, Abdalla EK, Kopetz S, Garrett CR, Overman MJ, Eng C, High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol 2011;29:1083–90.
   PubMed Web of Science ®Google Scholar
• Martin RC, Joshi J, Robbins K, Tomalty D, Bosnjakovik P, Derner M, Hepatic intra-arterial injection of drug-eluting bead, irinotecan (DEBIRI) in unresectable colorectal liver metastases refractory to systemic chemotherapy: results of multi-institutional study. Ann Surg Oncol 2011;18:192–8.
   PubMed Web of Science ®Google Scholar
• Goéré D, Deshaies I, de Baere T, Boige V, Malka D, Dumont F, Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases. Ann Surg 2010;251:686–91.
   PubMed Web of Science ®Google Scholar
• Elias D, Ouellet JF, Bellon N, Pignon JP, Pocard M, Lasser P. Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg 2003;90:567–74.
   PubMed Web of Science ®Google Scholar
• Elias D, Sideris L, Pocard M, Ouellet JF, Boige V, Lasser P, Results of R0 resection for colorectal liver metastases associated with extrahepatic disease. Ann Surg Oncol 2004;11:274–80.
   PubMed Web of Science ®Google Scholar
• Pulitanò C, Bodingbauer M, Aldrighetti L, de Jong MC, Castillo F, Schulick RD, Liver resection for colorectal metastases in presence of extrahepatic disease: results from an international multi-institutional analysis. Ann Surg Oncol 2010; Epub ahead of print.
   Web of Science ®Google Scholar
• Kemeny N, Huang Y, Cohen AM, Shi W, Conti JA, Brennan MF, Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999;341:2039–48.
   PubMed Web of Science ®Google Scholar
• Mitry E, Fields ALA, Bleiberg H, Labianca R, Portier G, Tu D, Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. J Clin Oncol 2008;26:4906–11.
   PubMed Web of Science ®Google Scholar
• Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. [see comment]. Lancet 2008;371:1007–16.
   PubMed Web of Science ®Google Scholar
• Sadahiro S, Suzuki T, Ishikawa K, Nakamura T, Tanaka Y, Masuda T, Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years. Hepatogastroenterology 2003;50:1362–6.
   PubMedGoogle Scholar
• McCormack PM, Burt ME, Bains MS, Martini N, Rusch VW, Ginsberg RJ. Lung resection for colorectal metastases: 10-year results. Arch Surg 1992;127:1403–6.
   PubMedGoogle Scholar
• International-Registry-of-Lung-Metastases. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. The international registry of lung metastases. J Thorac Cardiovasc Surg 1997;113:37–49.
   PubMed Web of Science ®Google Scholar
• Pfannschmidt J, Dienemann H, Hoffmann H. Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. Ann Thorac Surg 2007;84:324–38.
   PubMed Web of Science ®Google Scholar
• Primrose J, Treasure T, Fiorentino F. Lung metastasectomy in colorectal cancer: is this surgery effective in prolonging life? Respirology 2010;15:742–6.
   PubMed Web of Science ®Google Scholar
• Pfannschmidt J, Klode J, Muley T, Dienemann H, Hoffmann H. Nodal involvement at the time of pulmonary metastasectomy: experiences in 245 patients. Ann Thorac Surg 2006;81:448–54.
   PubMed Web of Science ®Google Scholar
• Treasure T, Fallowfield L, Lees B. Pulmonary metastasectomy in colorectal cancer: the PulMiCC trial. J Thorac Oncol 2010;5(6 Suppl 2):S203–6.
   PubMed Web of Science ®Google Scholar
• Lencioni R, Crocetti L, Cioni R, Suh R, Glenn D, Regge D, Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 2008;9:621–8.
   PubMed Web of Science ®Google Scholar
• Chua TC, Thornbury K, Saxena A, Liauw W, Glenn D, Zhao J, Radiofrequency ablation as an adjunct to systemic chemotherapy for colorectal pulmonary metastases. Cancer 2010;116:2106–14.
   PubMed Web of Science ®Google Scholar
• Miles WE. A method of performing abdomino-perineal excision for carcinoma of the rectum and of the terminal portion of the pelvic colon. Lancet 1908;ii:1812–13.
   Google Scholar
• Heald RJ, Ryall RDH. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986;327:1479–82.
   Google Scholar
• MacFarlane JK, Ryall RDH, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993;341:457–60.
   PubMed Web of Science ®Google Scholar
• Krook JE, Moertel CG, Gunderson LL, Wieand HS, Collins RT, Beart RW, Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324:709–15.
   PubMed Web of Science ®Google Scholar
• Peeters KCMJ, Marijnen CAM, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007;246:693–701.
   PubMed Web of Science ®Google Scholar
• Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 2009;373:811–20.
   PubMed Web of Science ®Google Scholar
• Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006;93:1215–23.
   PubMed Web of Science ®Google Scholar
• Bosset J-Fo, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006;355:1114–23.
   PubMed Web of Science ®Google Scholar
• Lingareddy V, Ahmad NR, Mohiuddin M. Palliative reirradiation for recurrent rectal cancer. Int J Radiat Oncol Biol Phys 1997;38:785–90.
   PubMed Web of Science ®Google Scholar
• Rhomberg W, Eiter H, Hergan K, Schneider B. Inoperable recurrent rectal cancer: results of a prospective trial with radiation therapy and razoxane. Int J Radiat Oncol Biol Phys 1994;30:419–25.
   PubMed Web of Science ®Google Scholar
• Wong CS, Cummings BJ, Brierley JD, Catton CN, McLean M, Catton P, Treatment of locally recurrent rectal carcinoma–Results and prognostic factors. Int J Radiat Oncol Biol Phys 1998;40:427–35.
   PubMed Web of Science ®Google Scholar
• Esnaola NF, Cantor SB, Johnson ML, Mirza AN, Miller AR, Curley SA, Pain and quality of life after treatment in patients with locally recurrent rectal cancer. J Clin Oncol 2002;20:4361–7.
   PubMed Web of Science ®Google Scholar
• Brændengen M, Tveit KM. Berglund Ãk, Birkemeyer E, Frykholm G, PÃ¥hlman L, et al. Randomized phase iii study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol 2008;26:3687–94.
   PubMed Web of Science ®Google Scholar
• Valentini V, Coco C, Rizzo G, Manno A, Crucitti A, Mattana C, Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: A prospective evaluation of a single institutional experience. Surgery 2009;145:486–94.
   PubMed Web of Science ®Google Scholar
• Govindarajan A, Coburn NG, Kiss A, Rabeneck L, Smith AJ, Law CHL. Population-based assessment of the surgical management of locally advanced colorectal cancer. J Natl Cancer Inst 2006;98:1474–81.
   PubMedGoogle Scholar
• Hansen MH, Balteskard L, Dørum LM, Eriksen MT, Vonen B. Locally recurrent rectal cancer in Norway. Br J Surg 2009;96:1176–82.
   PubMed Web of Science ®Google Scholar
• Wiig JN, Poulsen JP, Larsen S, Braendengen M, Waehre H, Giercksky KE. Total pelvic exenteration with preoperative irradiation for advanced primary and recurrent rectal cancer. Eur J Surg 2002;168:42–8.
   PubMedGoogle Scholar
• Ferenschild FT, Vermaas M, Verhoef C, Ansink AC, Kirkels WJ, Eggermont AM, Total pelvic exenteration for primary and recurrent malignancies. World J Surg 2009;337:1502–8.
   Google Scholar
• Goldberg JM, Piver MS, Hempling RE, Aiduk C, Blumenson L, Recio FO. Improvements in pelvic exenteration: factors responsible for reducing morbidity and mortality. Ann Surg Oncol 1998;5:399–406.
   PubMed Web of Science ®Google Scholar
• You YN, Habiba H, Chang GJ, Rodriguez-bigas MA, Skibber JM. Prognostic value of quality of life and pain in patients with locally recurrent rectal cancer. Ann Surg Oncol 2011;18:989–96.
   PubMed Web of Science ®Google Scholar
• Valentini V, Morganti AG, De Franco A, Coco C, Ratto C, Battista Doglietto G, Chemoradiation with or without intraoperative radiation therapy in patients with locally recurrent rectal carcinoma: prognostic factors and long term outcome. Cancer 1999;86:2612–24.
   PubMed Web of Science ®Google Scholar
• Dozois EJ, Privitera A, Holubar SD, Aldrete JF, Sim FH, Rose PS, High sacrectomy for locally recurrent rectal cancer: Can long-term survival be achieved? J Surg Oncol 2011;103:105–9.
   PubMed Web of Science ®Google Scholar
• Sagar PM, Gonsalves S, Heath RM, Phillips N, Chalmers AG. Composite abdominosacral resection for recurrent rectal cancer. Br J Surg 2009;96:191–6.
   PubMed Web of Science ®Google Scholar
• Birkmeyer JD, Siewers AE, Finlayson EVA, Stukel TA, Lucas FL, Batista I, Hospital volume and surgical mortality in the United States. N Engl J Med 2002;346:1128–37.
   PubMed Web of Science ®Google Scholar
• Hahnloser D, Nelson H, Gunderson LL, Hassan I, Haddock MG, O'Connell MJ, Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg 2003;237:502–8.
   PubMed Web of Science ®Google Scholar
• Asoglu O, Karanlik H, Muslumanoglu M, Igci A, Emek E, Ozmen V, Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience. Eur J Surg Oncol 2007;33:1199–206.
   PubMed Web of Science ®Google Scholar
• Wells BJ, Stotland P, Ko MA, Al-Sukhni W, Wunder J, Ferguson P, Results of an aggressive approach to resection of locally recurrent rectal cancer. Ann Surg Oncol 2007;14:390–5.
   PubMed Web of Science ®Google Scholar
• Dresen RC, Gosens MJ, Martijn H, Nieuwenhuijzen GA, Creemers GJ, Daniels-Gooszen AW, Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer. Ann Surg Oncol 2008;15:1937–47.
   PubMed Web of Science ®Google Scholar
• Pacelli F, Tortorelli AP, Rosa F, Bossola M, Sanchez AM, Papa V, Locally recurrent rectal cancer: prognostic factors and long-term outcomes of multimodal therapy. Ann Surg Oncol 2010;17:152–62.
   PubMed Web of Science ®Google Scholar
• Rahbari NN, Ulrich AB, Bruckner T, Munter M, Nickles A, Contin P, Surgery for locally recurrent rectal cancer in the era of total mesorectal excision - is there still a chance for cure? Ann Surg 2011;253:522–33.
   PubMed Web of Science ®Google Scholar
• Wiig JN, Larsen SG, Dueland S, Flatmark K, Giercksky KE. Salvage surgery for locally recurrent rectal cancer: total mesorectal excision during the primary operation does not influence the outcome. Colorectal Dis 2011;13:506–11.
   PubMed Web of Science ®Google Scholar